Tiverton Asset Management’s Biogen BIIB Stock Holding History

Tiverton Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$726K	Buy	3,116 +507	+19%	+$118K	0.03%	336
2019 Q2	$610K	Buy	2,609 +1,732	+197%	+$400K	0.02%	344
2019 Q1	$207K	Buy	+877	New	+$276K	0.01%	518
2018 Q4	–	Sell	-2,010	Closed	-$710K	–	493
2018 Q3	$710K	Sell	2,010 -71	-3%	-$24.4K	0.03%	221
2018 Q2	$604K	Buy	2,081 +1,372	+194%	+$386K	0.03%	234
2018 Q1	$194K	Sell	709 -1,212	-63%	-$376K	0.01%	318
2017 Q4	$612K	Buy	+1,921	New	+$616K	0.04%	220

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Tiverton Asset Management's BIIB Position: Q3 2019 in Review

Tiverton Asset Management increased its Biogen (BIIB) stake by 19% in Q3 2019, buying an estimated $118K and bringing the position to 3,116 shares worth $726K. The position accounts for 0.03% of the portfolio, ranked #336.

Tiverton Asset Management first reported a position in BIIB in Q4 2017 and has held it in 7 quarters since. 988 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

Tiverton Asset Management held 3,116 shares of Biogen worth $726K as of Q3 2019.
Tiverton Asset Management bought 507 Biogen shares in Q3 2019, an estimated $118K.
Biogen made up 0.03% of Tiverton Asset Management's portfolio in Q3 2019, its #336 holding.
Tiverton Asset Management first reported a position in Biogen in Q4 2017 and has held it in 7 quarters since.
988 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.